TraceLink Partners with Genpact to Expand Delivery of Digital Supply Chain Innovation for Healthcare and Life Sciences Sectors

June 11, 2024 12:06 AM IST | By Cision
 TraceLink Partners with Genpact to Expand Delivery of Digital Supply Chain Innovation for Healthcare and Life Sciences Sectors
Image source: Kalkine Media

TraceLink and Genpact solve supply chain complexities with advanced digital orchestration solutions.

BOSTON, June 11, 2024 /PRNewswire/ -- TraceLink, a global leader in digital supply chain solutions, announced it has partnered with Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, to expand delivery of digital supply chain solutions and innovation within the healthcare and life sciences sectors. The combination of TraceLink's advanced technology for supply chain digitalization and Genpact's expertise in data, technology, and AI solutions for supply chain management is providing healthcare and life sciences customers with unmatched benefits to orchestrate better outcomes across their end-to-end supply chains, including improved cost, service, predictability and resiliency.

"Supply chain pressures in life sciences and healthcare are increasingly complex due to technological advancements, innovative treatments, and global trade disruptions," said Erich Gampenrieder, Global Head of Supply Chain Strategy and Growth at Genpact. "Partnering with TraceLink, we are leveraging our data, technology, AI-first approach, and supply chain transformation expertise to tackle these challenges. Our combined deep knowledge of life sciences and healthcare is enabling us to transform how organizations manage and optimize their supply chains, driving effectiveness, efficiency, and innovation in the industry."

Genpact's deep expertise in Supply Chain Management (SCM) is complemented by TraceLink's extensive network of 291,000+ industry-specific entities and its proven solution, Multienterprise Information Network Tower (MINT). This partnership enables businesses in the pharmaceutical industry to build comprehensive digitalization strategies, rapidly and cost-effectively link their ERP and other enterprise systems to a real-time network of partners to access real-time supply chain data and orchestrates multi-enterprise business relationships with partners to significantly improve visibility and collaboration.

"Genpact's proven track record in driving supply chain transformation, coupled with TraceLink's unparalleled technology platform, Opus, creates a synergy that will propel companies towards achieving digital supply chain orchestration like never before," said Shabbir Dahod, President and CEO of TraceLink.

Furthermore, the combination of TraceLink's advanced technology for supply chain digitalization with Genpact's digital transformation expertise enables leaders in life sciences companies—COOs, CSCO, and leaders in logistics and distribution—to maximize the potential of TraceLink's Integrate-Once, Interoperate with Everyone™ capabilities. This strategic alliance extends the reach of TraceLink's products for companies seeking comprehensive digital supply chain solutions and leverages Genpact's approach to tackling business challenges from the top down.

To learn more visit TraceLink's partnership page. 

Upcoming Webinar

Meet TraceLink and Genpact at Gartner Symposium/Xpo™ 2024, June 10th to 12th in Barcelona at Kiosk 216 or discover more about how this partnership can revolutionize supply chain operations by joining an upcoming webinar.

About TraceLink

TraceLink is a leading provider of digital supply chain solutions that deliver unprecedented visibility, enabling companies to protect patients, ensure compliance, and optimize their supply chain operations. The TraceLink cloud-based platform provides a single point of information sharing and collaboration for all supply chain partners, leveraging advanced analytics and machine learning to drive actionable insights. With TraceLink, businesses can achieve end-to-end supply chain visibility and forge stronger connections with their partners, ensuring the availability and integrity of lifesaving medications for patients worldwide. For more information visit tracelink.com.

Media Contact:
Erica Burns
[email protected]

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.